The clinical, diagnostic and therapeutic aspects of amnestic mild cognitive impairment
The article examines the prevalence, causes and main clinical manifestations of amnestic mild cognitive impairment - a syndrome which in most cases is the first manifestation of the neurodegenerative Alzheimer's disease. Diagnostic approaches and the possibility of differential diagnosis are highlighted. There is data on the effectiveness of the glutamate NMDA-receptors antagonist - memantine - in patients with moderate cognitive impairment. The efficacy and safety of Akatinol Memantine as a medication to improve cognitive function is highlighted.